Monte Rosa Therapeutics, Inc. (GLUE)

NASDAQ: GLUE · Real-Time Price · USD

Compare

10.04

+1.58 (18.68%)

At close: Oct 10, 2025, 4:00 PM EDT

9.82

-0.22 (-2.19%)

After-hours: Oct 10, 2025, 7:59 PM EDT

Monte Rosa Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	69.43	224.25	128.1	54.91	346.07	41.7
Short-Term Investments	221.17	147.9	104.31	207.91	-	-
Cash & Short-Term Investments	290.59	372.15	232.41	262.83	346.07	41.7
Cash Growth	10.83%	60.12%	-11.57%	-24.05%	729.93%	-
Other Receivables	2.37	0.17	0.51	7.66	-	-
Total Trade Receivables	2.37	0.17	0.51	7.66	-	-
Other Current Assets	6.5	5.12	3.29	5.4	2.6	1.89
Total Current Assets	299.47	377.44	236.21	275.89	348.67	43.59
Net Property, Plant & Equipment	54.73	56.31	62.61	61.91	12.33	4.62
Other Long-Term Assets	5.4	4.98	4.93	4.6	5.34	1.16
Total Assets	359.59	438.73	303.76	342.39	366.33	49.38
Accounts Payable	5.58	17.22	11.15	7.86	6.56	7.07
Accrued Expenses	13.77	18.79	14.6	14.58	10.08	2.53
Current Portion of Leases	4.09	3.71	3.16	3.13	-	-
Unearned Revenue	18.41	117.23	17.68	-	-	-
Other Current Liabilities	-	-	-	-	-	19.68
Total Current Liabilities	41.85	156.95	46.59	25.57	16.64	29.28
Long-Term Leases	37.04	39	42.88	43.87	-	-
Other Long-Term Liabilities	12.62	19.85	35.04	1.53	2.18	1.07
Total Long-Term Liabilities	49.65	58.85	77.91	45.41	2.18	1.07
Total Liabilities	91.51	215.8	124.51	70.98	18.81	30.34
Preferred Stock	-	-	-	-	-	67.76
Common Stock	0.01	0.01	0.01	0.01	0.01	0
Additional Paid-in Capital	675.45	664.87	547.86	503.7	471.57	0.4
Accumulated Other Comprehensive Income	-3.37	-3.36	-2.72	-1.75	-2.02	-1.06
Retained Earnings	-404	-438.59	-365.89	-230.54	-122.04	-48.08
Shareholders' Equity	268.08	222.94	179.25	271.41	347.52	-48.73
Total Liabilities & Equity	359.59	438.73	303.76	342.39	366.33	49.38
Total Debt	41.13	42.72	46.04	47	0	0
Net Cash (Debt)	249.46	329.43	186.37	215.83	346.07	41.7
Net Cash Growth	-24.27%	76.76%	-13.65%	-37.64%	729.93%	-
Net Cash Per Share	3.03	4.46	3.63	4.57	13.84	27.49
Book Value	268.08	222.94	179.25	271.41	347.52	-48.73
Book Value Per Share	3.26	3.02	3.49	5.75	13.90	-32.12
Tangible Book Value	268.08	222.94	179.25	271.41	347.52	-48.73
Tangible Book Value Per Share	3.26	3.02	3.49	5.75	13.90	-32.12

Updated Aug 7, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q